Synergy between biopharma and academia
Pivot Park is an incubator for ideation, innovation, and development. With its large regional and international network in biopharma, Pivot
Dr. Saman Honarnejad member of Drug Repurposing Advisory Board at Oncode institute
Dr. Saman Honarnejad, Director of Drug Discovery at Pivot Park Screening Centre has been appointed as an external member of
In a paper recently published in the SLAS Discovery Journal of Biomolecular Screening, European Lead Factory (ELF) scientists from Pivot
The European Lead Factory selects first COVID-19 proposal
Over the last few months, as the world has grappled with the COVID-19 pandemic, the European Lead Factory has been
One of the sub-projects of the MMV-PDP Consortium recently received funding from the Bill and Melinda Gates Foundation, to further develop an
Novel Screening Assay for Arginase-1 Inhibitors published in SLAS Discovery
Arginase-1 is a promising new drug target for cancer immunotherapy. A novel assay technology for High-Throughput Screening (HTS) of Arginase-1
Pivot Park – Banting Building (RE2423)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park – RE2423
Industrielaan 63
5349 AE Oss
The Netherlands
